DIAGNOSTICO DIFERENCIAL HEPATOCARCINOMA PDF

Hepatocarcinoma fibrolamelar un tumor de adultos jóvenes poco frecuente. . Dentro de los diagnósticos diferenciales se debe considerar la HNF, CHC. Protocolo de diagnóstico diferencial de las lesiones ocupantes de espacio en el hígado cirrótico Clinical management of hepatocellular carcinoma. Su diagnóstico suele ser tardío, ya que se presenta en pacientes jóvenes, sin . a las del hepatocarcinoma en la que es necesario un diagnóstico diferencial.

Author: Mezidal Jukora
Country: Uzbekistan
Language: English (Spanish)
Genre: Politics
Published (Last): 19 March 2008
Pages: 70
PDF File Size: 12.48 Mb
ePub File Size: 7.90 Mb
ISBN: 495-2-69142-210-7
Downloads: 59915
Price: Free* [*Free Regsitration Required]
Uploader: Jutaur

The utilization of hepatobiliary contrast agents may reduce the necessity of invasive diagnostic procedures as well as of further investigation with other imaging methods, and imaging follow-up, reducing costs and the anxiety of both patients and medical team. Is fibrolamellar carcinoma different from hepatocellular carcinoma? Imaging evaluation of congenital cystic lesions of the biliary tract. However, considering that hemangiomas are common lesions, they will be frequently present on images acquired with hepatobiliary contrast diagnodtico several reasons.

The differentiation between HCC and perfusion alterations may also represent a diagnostic challenge. The utilization of hepaocarcinoma contrast agents increases the MRI accuracy, reducing the necessity of invasive diagnostic procedures intended to clarify the diagnosis of nonspecific lesions 12.

Magnetic resonance imaging is considered the best imaging method for evaluating such lesions, but does not allow for the diagnosis in all cases.

HEPATOCARCINOMA DE CÈLULAS CLARAS by marta garnica ureña on Prezi

A US population-based study. Prevalence of simple liver cysts and hemangiomas in cirrhotic and non-cirrhotic patients submitted to magnetic resonance imaging.

Female, year-old patient presenting with colon cancer. Focal liver lesions enhancement may be less intense during the dynamic study, particularly in the arterial phase, because the recommended dose of gadoxetic acid is lower than the habitual extracellular gadolinium dose 5.

However, the differentiation between FNH and adenoma is not always easy at conventional MRI, because both conditions may appear as nonspecific diferenfial lesions, generating anguish for diferenciao patient and challenging the physician, in addition to the cost and patient’s anxiety with repeated examinations.

Additionally, hepatobiliary contrast agents allow for evaluating the biliary tract 1 – 3. Hemangiomas present the same imaging findings at dynamic studies with hepatobiliary contrast; however, in the delayed phase, as the hepatobiliary contrast medium is leaving the interstitium and entering into the functioning hepatocytes, the hemangioma fill-in might or might not occur in this phase, differing from its usual behavior with the use of extracellular gadolinium Cancer ; On the other hand, the enhancement diagnnostico the hepatobiliary phase is prolonged, allowing for acquisition of images with better spatial resolution, as well as its repetition in case of imaging artifacts 4.

  CATALOGO SKF CUSCINETTI PDF

Review of the clinicopathologic features of fibrolamellar carcinoma. The presence of intralesional fat and the absence of hepatobiliary contrast uptake indicate a probable diagnosis of adenoma. Radiol Clin North Am ; Imaging of fibrolamellar hepatocellular carcinoma. Imaging findings in the hepatobiliary findings should be always analyzed in the clinical context, considering the lesion signal characteristics on anatomical sequences. Adverse effects of hepatobiliary contrast agents rarely occur and, if present, are similar to the ones reported in the use of extra-cellular gadolinium.

There was a problem providing the content you requested

The currently available hepatocyte-selective contrast media are the following: Cancer ; 6: On the other hand, poorly-differentiated or undifferentiated hepatocarcinomas do not contain functioning hepatocytes and do not show hepatobiliary contrast uptake, remaining hypointense in relation to the surrounding parenchyma 21017 – 19 Figure 6.

Fibrolamellar carcinoma of the liver: Hepatobiliary contrast uptake by HCCs depends on the tumor differentiation stage diaggnostico on the amount of functioning hepatocytes 24. Additionally, as compared with healthy livers, cirrhotic livers present later enhancement peak and slower washout 32 – Thus, in the hepatobiliary phase, most adenomas are hypointense in relation to the surrounding parenchyma Figure 3.

A potential confusion factor is the fact that some hemangiomas may present subtle central contrast uptake during the early hepatobiliary phase because of the tendency to persistent centripetal enhancement at dynamic study, like in those with extracellular gadolinium 1. New proposal for the staging of nonalcoholic steatohepatitis: Several studies are evaluating the relation between the degree of hepatic fibrosis in patients with cirrhosis As well as the hepatobiliary contrast enhancement with the objective of reducing the necessity of biopsies currently considered a gold standard.

Reporte de un caso. Eur J Cancer ; 49 The pharmacokinetics and doses of gadobenate dimeglumine and gadoxetic acid are different. Fibrolamellar variant of hepatocellular carcinoma. Hemangiomas generally present typical imaging findings and are easily diagnosed by computed tomography or MRI with extracellular gadolinium contrast agent.

  IC TL071 PDF

As gadobenate dimeglumine is utilized, it is recommended that the MRI study be performed as usual, including the dynamic study up to the delayed phase; then the procedure be interrupted and the patient returns after minutes for acquisition of the hepatobiliary phase.

Gastrointestinal tumors of childhood.

The diagnosis of sphincter of Oddi dysfunction can be based on the finding of absent or delayed passage of the hepatobiliary contrast thru the ampulla of Vater. Thus, the lesions enhancement in the hepatobiliary phase depends upon the expression and activity of such transporters, determining characteristic enhancement patterns depending on the presence or absence of functioning hepatocytes.

Received Jul 23; Accepted Oct Fibrolamellar hepatocellular carcinoma presenting with Budd-Chiari syndrome, right atrial thrombus, and pulmonary emboli. Male, year-old patient presenting with colon cancer and multiple metastases, with hyposignal on T1-weighted, and subtle hypersignal on T2-weighted sequence. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid Gd-EOB-DTPA for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.

Other applications of hepatobiliary contrast agents include the evaluation of the biliary flow dynamics, the study of partial or complete biliary duct obstructions, and the localization of the stenosis site.

A fraction of hepatobiliary contrast agent is excreted by cMOAT into the biliary canaliculi multispecific canalicular organic anion transporter 1. However, in some cases, especially those of small lesions without central scarone cannot differentiate between FNH and adenoma due to overlapping imaging findings 14.

Primary diferencal malignant neoplasms.

The most frequent differential diagnoses for hypervascular lesions in patients with no hepatopathy include hemangioma, FNH and adenoma. Journal List Radiol Bras v. Docente Universidad de Antioquia.